TipRanks
Go Ultimate55% OFF

Ayalon Hold. (AYAL) AI Stock Analysis

IL:AYAL

Ayalon Hold.

(TASE:AYAL)

Select Model
Rating:76Outperform
Price Target:ILA 20,363.00â–²(22.82% Upside)
Action:reiterated
Date:08/24/26

The overall score reflects solid but cash‑flow‑risky financial performance as the most important factor, combined with an attractive valuation and a strong price uptrend with firm momentum. The key upside drivers are low‑teens valuation metrics and improving earnings with reduced leverage, while the main risk that tempers the score is the history of volatile and recently negative operating and free cash flows, which may challenge the sustainability of current returns.

Positive Factors
Improved Profitability and ScaleRevenue and net income have improved meaningfully since 2023, showing recovery in the operating business and greater earnings scale. This stronger base can support continued investment and resilience, although the earnings trajectory remains cyclical rather than uniformly upward.
Negative Factors
Negative Operating and Free Cash FlowRecent earnings are not translating into cash, with both operating and free cash flow negative after positive results in 2024–2025. Persistent cash conversion weakness could increase reliance on liquidity or financing and constrain the company’s ability to fund growth internally.

Ayalon Hold. (AYAL) vs. iShares MSCI Israel ETF (EIS)

-50%0%50%100%150%200%IL:AYAL+136.15%EIS+13.14%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
ILS 4.70B
Dividend Yield
2.83%
Average Volume (3M)
91.31K
Price to Earnings (P/E)
9.9
Beta (1Y)
1.61
Revenue Growth
―
EPS Growth
―
Country
Israel
Employees
1,369
Sector
General
Sector Strength
55
Industry
Insurance - Diversified

Ayalon Hold. Business Overview & Revenue Model

Company Description

Operating through its subsidiaries in Israel, Ayalon Insurance Company Ltd offers a comprehensive range of insurance products. Their health coverage extends to nursing care, medical expenses, surgical procedures and organ transplants, dental services...

How the Company Makes Money

null

Ayalon Hold. Financial Statement Overview

Summary

Strong revenue and earnings growth with high recent margins and returns on equity, supported by lower leverage, but the overall score is constrained by volatile and sometimes negative operating and free cash flows that raise questions about the durability of profits.

Income Statement

84Very Positive

Balance Sheet

78Positive

Cash Flow

43Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.08B5.54B4.37B3.66B2.35B3.15B
Gross Profit6.19B5.54B3.87B3.19B1.90B2.73B
EBITDA675.65M777.74M389.55M283.39M312.60M1.62M
Net Income442.45M426.07M144.41M84.91M166.68M-114.09M
Balance Sheet
Total Assets24.25B20.07B19.07B15.94B15.58B16.02B
Cash, Cash Equivalents and Short-Term Investments1.03B2.71B3.60B410.07M3.23B3.08B
Total Debt1.03B690.27M734.34M697.08M732.66M793.57M
Total Liabilities22.46B18.55B18.09B15.24B14.94B15.34B
Stockholders Equity1.79B1.52B971.34M703.49M638.27M679.24M
Cash Flow
Free Cash Flow-251.01M187.87M81.33M-70.05M227.81M-389.21M
Operating Cash Flow-174.68M309.67M208.64M-65.06M335.35M-306.02M
Investing Cash Flow-103.25M-117.58M-122.87M-104.22M-5.44M-82.55M
Financing Cash Flow391.05M-54.50M-49.60M-8.96M-66.42M143.92M

Ayalon Hold. Technical Analysis

Technical Analysis SentimentNeutral
Last Price16580.00

Price Trends

50DMA17630.39Negative
100DMA15812.23Positive
200DMA14583.22Positive

Market Momentum

MACD-11.19Positive
RSI38.90Neutral
STOCH18.94Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AYAL, the sentiment is Neutral. The current price of 16580.00 is below the 20-day moving average (MA) of 17855.50, below the 50-day MA of 17630.39, and above the 200-day MA of 14583.22, indicating a neutral trend. The MACD of -11.19 indicates Positive momentum. The RSI at 38.90 is Neutral, neither overbought nor oversold. The STOCH value of 18.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:AYAL.

Ayalon Hold. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IL:AYAL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:IDINIL:IDIN80OutperformILS 3.69B9.99―7.59%3.98%14.95%
IL:MMHDIL:MMHD77OutperformILS 30.86B12.32―3.24%18.14%49.80%
IL:AYALIL:AYAL76OutperformILS 4.70B9.93―2.83%――
IL:PHOEIL:PHOE75OutperformILS 42.92B12.94―3.25%10.88%24.40%
IL:HARLIL:HARL71OutperformILS 37.11B11.3223.23%3.85%14.74%70.44%
IL:CLISIL:CLIS65NeutralILS 21.75B9.05―1.84%-30.50%67.45%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%50%100%150%IL:AYALIL:CLISIL:HARLIL:PHOEIL:MMHDIL:IDINDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IL:AYAL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:AYALAyalon Holdings Ltd.16580.009945.78149.92%
IL:CLISClal Insurance Enterprises Holdings 26900.009065.4650.83%
IL:HARLHarel Insurance Investments & Financial Services 18060.007109.6164.93%
IL:PHOEPhoenix Holdings Ltd.17000.004809.4839.45%
IL:MMHDMenora Mivtachim Holdings Ltd.49390.0018067.1757.68%
IL:IDINI.D.I. Insurance Company Ltd.24950.006556.5735.65%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 24, 2026